TGFB1 and idiopathic pulmonary fibrosis: In addition, bortezomib effectively inhibit TGF-β1-mediated target gene expression by inhibiting Smads activated transcription in primary human lung fibroblasts from normal individuals and patients with IPF, and in skin fibroblasts from patients with scleroderma.